Analysis of factors influencing the self-regulation of medication and construction of an educational program for patients with chronic hepatic diseases
N. Iihara et al., Analysis of factors influencing the self-regulation of medication and construction of an educational program for patients with chronic hepatic diseases, YAKUGAKU ZA, 120(7), 2000, pp. 644-651
Citations number
11
Categorie Soggetti
Pharmacology & Toxicology
Journal title
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
The purpose of this study is to construct an educational program for patien
ts with chronic hepatic diseases to avoid self-regulation of medication. We
have statistically analyzed the influencing factors of self-regulation fro
m the following 3 viewpoints. First, in the investigation of the number of
and the kind of prescribed medicines, it was found that the number of presc
ribed medicines increased sharply at the stage of Liver Cirrhosis b. Second
ly, in the survey of patients' awareness of medication, it was found that s
elf-regulation was influenced by lack of understanding the effects of medic
ines and the necessity of medication, and by lack of understanding the clin
ical conditions. Especially, at the stage of Liver Cirrhosis b, self-regula
tion was strongly influenced by lack of understanding the clinical conditio
ns. Lastly, in the evaluation of patients' characteristics by pharmacists,
self-regulation was also strongly influenced by the level of understanding
the necessity of medication, understanding the clinical conditions, a patie
nt-doctor relationship, and anxiety about side-effects of medicines. Theref
ore we have constructed an educational program for patients from the viewpo
int of medication. The information consists of two articles; one is the act
ion mechanism of the medicine connected with the clinical conditions to hel
p the patients understand the necessity of medication; the other is how to
check the effect and adverse reaction of the medication by themselves to de
crease the anxiety about side-effects. Consequently, the medication managem
ent and the consultation for inpatients with chronic hepatic diseases were
standardized by incorporating the education with the information described
above.